InvestorsHub Logo
Followers 276
Posts 32701
Boards Moderated 0
Alias Born 11/14/2013

Re: ou71764 post# 2968

Saturday, 12/21/2013 11:05:31 AM

Saturday, December 21, 2013 11:05:31 AM

Post# of 700553
OU,

I agree, a partnership with a larger company to complete a phase three trial on DCVAX-Prostate would be amazing. I was a little tongue-in-cheek about Inovio having the ability to bid against BMY. Dr. Kim curiously threw NWBO in with synthetic treatments, and my guess he is that he simply misspoke. However, by misspeaking, he shared volumes about why NWBO is a superior strategy (and I believe will have superior results to ICT-107 and Provenge). That said, Inovio may offer great synergy to DCVax. In the end, I think we will see a immunotherapy cocktail that will likely be primarily based upon DCVAX with other immuno-adjuncts. Whether these will be administered simultaneously or in some critical order is yet to be determined.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News